Agonist-evoked Ca2+ signals through the activation of Orai1 also fine tune breast cancer cell functions as described in triple negative breast cancer cells where progesterone attenuates cell proliferation by a mechanism involving Ca2+ entry mediated by STIM2, Orai1, and TRPC1 [39]. Here, ORAI1 is linked to triple-negative breast carcinoma.